Invalid Symbol

Stock Research for RGDX

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


RGDX Stock Chart & Research Data

The RGDX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RGDX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


RGDX Due diligence Resources & Stock Charts

The RGDX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RGDX Detailed Price Forecast - CNN Money CNN View RGDX Detailed Summary - Google Finance
Yahoo View RGDX Detailed Summary - Yahoo! Finance Zacks View RGDX Stock Research & Analysis -

Stock Analysis

TradeIdeas View RGDX Trends & Analysis - Trade-Ideas Barrons View RGDX Major Holders - Barrons
NASDAQ View RGDX Call Transcripts - NASDAQ Seeking View RGDX Breaking News & Analysis - Seeking Alpha
Spotlight View RGDX Annual Report - OTC Report View RGDX OTC Short Report -
TradeKing View RGDX Fundamentals - TradeKing Charts View RGDX SEC Filings - Bar Chart
WSJ View Historical Prices for RGDX - The WSJ Morningstar View Performance/Total Return for RGDX - Morningstar
MarketWatch View the Analyst Estimates for RGDX - MarketWatch CNBC View the Earnings History for RGDX - CNBC
StockMarketWatch View the RGDX Earnings - StockMarketWatch MacroAxis View RGDX Buy or Sell Recommendations - MacroAxis
Bullish View the RGDX Bullish Patterns - American Bulls Short Pains View RGDX Short Pain Metrics -

Social Media Mentions

StockTwits View RGDX Stock Mentions - StockTwits PennyStocks View RGDX Stock Mentions - PennyStockTweets
Twitter View RGDX Stock Mentions - Twitter Invest Hub View RGDX Investment Forum News - Investor Hub
Yahoo View RGDX Stock Mentions - Yahoo! Message Board Seeking Alpha View RGDX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for RGDX - Insider Cow View Insider Transactions for RGDX - Insider Cow
CNBC View RGDX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RGDX - OTC Markets
Yahoo View Insider Transactions for RGDX - Yahoo! Finance NASDAQ View Institutional Holdings for RGDX - NASDAQ

Stock Charts

FinViz View RGDX Stock Insight & Charts - StockCharts View RGDX Investment Charts -
BarChart View RGDX Stock Overview & Charts - BarChart Trading View View RGDX User Generated Charts - Trading View

Latest Financial News for RGDX

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Response Genetics Inc. Enters Into Asset Purchase Agreement With Cancer ...
GlobeNewswire (press release) - Aug 10, 2015
LOS ANGELES, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (OTCQB:RGDX) (the "Company"), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, announced today ...
Response Genetics Files Bankruptcy, Finds Buyer - Los Angeles Business Journal
Response Genetics Files for Chapter 11 Protection; Enters $14M Deal to Sell ... - GenomeWeb

Myriad Genetics: Analyzing The Qualms Over The Multiple
Seeking Alpha - Feb 9, 2018
In late January, it was suggested the market's multiple for Myriad Genetics (at 30) was too high. Most investors would agree market multiples should be justifiable.

Myriad Announces GeneSight® Psychotropic Results from a Large Prospective ...
GlobeNewswire (press release) - Nov 2, 2017
SALT LAKE CITY, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc.

Why Shares of Seattle Genetics, Inc. Got Whacked Today
Motley Fool - Jun 26, 2017
Seattle Genetics' ECHELON-1 trial tested Adcetris, which is already approved as a treatment for Hodgkin lymphoma after stem cell transplantation, in combination with older chemotherapy drugs -- adriamycin, vinblastine, dacarbazine (AVD) -- compared to ...
Seattle Genetics slumps as cancer drug data fails to impress - Reuters
Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 ... - Business Wire (press release)

Enter a stock symbol to view the stock details.